Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 34.11 Billion KRW | 4.0% |
| 2022 | 32.8 Billion KRW | 30.67% |
| 2021 | 25.1 Billion KRW | -0.1% |
| 2020 | 25.12 Billion KRW | 41.19% |
| 2019 | 17.79 Billion KRW | 33.76% |
| 2018 | 13.3 Billion KRW | -9.22% |
| 2017 | 14.65 Billion KRW | 27.95% |
| 2016 | 11.45 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 35.37 Billion KRW | -0.27% |
| 2024 Q1 | 35.47 Billion KRW | 3.98% |
| 2023 Q1 | 34.9 Billion KRW | 6.39% |
| 2023 FY | 34.11 Billion KRW | 4.0% |
| 2023 Q4 | 34.11 Billion KRW | 5.54% |
| 2023 Q3 | 32.32 Billion KRW | -5.71% |
| 2023 Q2 | 34.28 Billion KRW | -1.77% |
| 2022 Q2 | 27.74 Billion KRW | 7.29% |
| 2022 Q4 | 32.8 Billion KRW | 4.04% |
| 2022 Q3 | 31.52 Billion KRW | 13.65% |
| 2022 FY | 32.8 Billion KRW | 30.67% |
| 2022 Q1 | 25.85 Billion KRW | 3.0% |
| 2021 Q3 | 26.01 Billion KRW | 0.0% |
| 2021 Q4 | 25.1 Billion KRW | -3.51% |
| 2021 FY | 25.1 Billion KRW | -0.1% |
| 2020 FY | 25.12 Billion KRW | 41.19% |
| 2019 FY | 17.79 Billion KRW | 33.76% |
| 2018 FY | 13.3 Billion KRW | -9.22% |
| 2017 FY | 14.65 Billion KRW | 27.95% |
| 2016 FY | 11.45 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Co., Ltd. | 11.42 Billion KRW | -198.704% |
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -3274.191% |
| BINEX Co., Ltd. | 28.26 Billion KRW | -20.718% |
| Bioneer Corporation | 41.35 Billion KRW | 17.502% |
| Anterogen.Co.,Ltd. | 1.91 Billion KRW | -1685.737% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | -135.013% |
| CrystalGenomics, Inc. | 1.55 Billion USD | -2094.287% |
| Helixmith Co., Ltd | 914.11 Million KRW | -3632.203% |
| Medy-Tox Inc. | 59.61 Billion KRW | 42.775% |
| Peptron, Inc. | 172.18 Million KRW | -19713.646% |
| Amicogen, Inc. | 46.83 Billion KRW | 27.16% |
| Genexine, Inc. | 3.8 Billion KRW | -796.17% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | -539.388% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | -17232.639% |
| ALTEOGEN Inc. | 1.06 Billion KRW | -3093.364% |
| PharmaResearch Co., Ltd. | 50.23 Billion KRW | 32.082% |
| SillaJen, Inc. | 1.21 Billion KRW | -2713.45% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | -167.772% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | -7183.501% |
| Genomictree Inc. | 496.53 Million KRW | -6770.984% |
| MedPacto, Inc. | 620.00 KRW | -5502676338.387% |
| D&D Pharmatech | 3.45 Billion KRW | -888.824% |
| EASY BIO,Inc. | 25.93 Billion KRW | -31.528% |
| GI Innovation, Inc. | - KRW | -Infinity% |